Pfizer launches new antibiotic in the UK
Pfizer’s antibiotic Zavicefta has now been launched in the UK to treat serious aerobic Gram-negative infections caused by resistant bacteria.
Read More
Tag: avibactam
US regulators expand use of Allergan’s antibiotic
The US Food and Drug Administration has agreed to expand the label of Dublin, Ireland-based Allergan’s Avycaz to include the treatment of complicated urinary tract infections (cUTI).
Read More
EU clears AstraZeneca’s new antibiotic
AstraZeneca’s Zavicefta has been approved for use in the European Union to treat patients with serious Gram-negative bacterial infections requiring hospitalisation.
Read More
- Laigo Bio completes final close of €17m seed financing round
- Axplora announces expansion as newest part of $60m API investment programme
- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
